Redox imbalance in patients with coronary artery disease showing progression of atherosclerotic lesions

Journal of Cardiology

Volumn 48, Issue 4, 2006, Pages 183-191

  Tsuru, Rie ^a   Hojo, Yukihiro ^a   Gama, Miyuki ^a   Mizuno, Osamu ^a   Katsuki, Takaaki ^a   Shimada, Kazuyuki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Antioxidants (enzyme); Atherosclerosis; Coronary artery disease; Interventional cardiology (percutaneous coronary intervention); Stress (oxidative)

Indexed keywords

GLUTATHIONE; GLUTATHIONE PEROXIDASE; LIPID PEROXIDE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD; CORONARY ARTERY ATHEROSCLEROSIS; ENZYMOLOGY; ERYTHROCYTE; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; OXIDATION REDUCTION REACTION; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY RESTENOSIS; ERYTHROCYTES; FEMALE; FOLLOW-UP STUDIES; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HUMANS; LIPID PEROXIDES; MALE; MIDDLE AGED; OXIDATION-REDUCTION;

EID: 39049178983     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Halliwell B: Free radicals, reactive oxygen species and human disease: A critical evaluation with special reference to atherosclerosis. Br J ExpPathol 1989; 70: 737-757
2. McCord JM: Oxygen-derived radicals: A link between reperfusion injury and inflammation. Fed Proc 1987; 46: 2402-2406
3. Dhalla NS, Temsah RM, Netticadan T: Role of oxidative stress in cardiovascular diseases. J Hypertens 2000; 18: 655-673
4. Lopez Fane A, Casado S: Heart failure, redox alterations, and endothelial dysfunction. Hypertension 2001 ; 38: 1400-1405
5. Orie NN, Zidek \V, Tepel M: Reactive oxygen species in essential hypertension and non-insulin-dependen.t diabetes mellitus. Am J Hypertens 1999; 12: 1169-1174
6. Cai H, Harrison DG: Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circ Res 2000; 87: 840-844
7. Suematsu T, Kamada T, Abe H, Kikuchi S, Yagi K: Serum lipoperoxide level in patients suffering from liver disease. ClinChimActa 1977; 79: 267-270
8. Sato Y, Hotta N, Sakamoto N, Matsuoka S, Ohishi N, Yagi K: Lipid peroxide level in plasma of diabetic patients. BiochemMed 1979; 21: 104-107
9. Harman D: The free-radical theory of aging, in Free Radicals in Biology (ed by Pryor WA), Vol. 5. Academic Press, New York, 1982; pp 255-275
10. Mezzetti A, Pierdomenico SD, Costantini F, Romano F, De Cesare D, Cuccurullo F, Imbastaro T, Riario-Sforza G, Di Giacomo F, Zuliani G, Fellin R: Copper/zinc ratio and systemic oxidant load: Effect of aging and aging-related degenerative diseases. Free Radic Biol Med 1998; 25: 676-681
11. Tuzcu EM, Kapadia SR, Sachar R, Ziada KM, Crowe TD, Feng J, Magyar WA, Hobbs RE, Starling RC, Young JB, McCarthy P, Nissen SE: Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation. J Am Coll Cardiol 2005; 45: 1538-1542
12. Paglia DE, Valentine WN: Studies on the quantitative and qualitative characterization of erythrocyte glutathione per-oxidase. J Lab Clin Med 1967; 70: 158-169
13. Ohishi N, Ohkawa H, Miike A, Tateno T, Yagi K: A new assay method for lipid peroxides using a methylene blue derivative. Biochem Int 1985; 10: 205-211
14. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW: Angiotensin II stimulates NADH and NADPH oxi-dase activity in cultured vascular smooth muscle cells. Circ Res 1994; 74: 1141-1148
15. Brown BG, Zhao X-Q, Chait A, Fisher LD, Cheung MC, Morse JS, Dowdy AA, Marino EK, Bolson EL, Alaupovic P, Frohlich J, Albers JJ: Simvastatin and niacin, antioxi-dant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 2001; 345: 1583-1592
16. Linke A, Adams V, Schulze PC, Erbs S, Gielen S, Fiehn E, Mobius-Winkler S, Schubert A, Schuler G, Hambrecht R: Antioxidative effects of exercise training in patients with chronic heart failure: Increase in radical scavenger enzyme activity in skeletal muscle. Circulation 2005; 111: 1763-1770
17. Dincer Y, Akcay T, Konukoglu D, Hatemi H: Erythrocyte susceptibility to lipid peroxidation in patients with coronary atherosclerosis. Acta Med Okayama 1999; 53: 259-264
18. Miquel J, Ramirez-Bosca A, Soler A, Diez A, Carrion-Gutierrez MA, Diaz-Alperi J, Quintanilla-Ripoll E, Bemd A, Quintanilla-Almagro E: Increase with age of serum lipid peroxides: Implications for the prevention of atherosclerosis. Mech Ageing Dev 1998; 100: 17-24
19. Hojo Y, Saito Y, Tanimoto T, Hoefen RJ, Baines CP, Yamamoto K, Haendeler J, Asmis R, Berk BC: Fluid shear stress attenuates hydrogen peroxide-induced c-Jun NH2-terminal kinase activation via a glutathione reductase-medi-ated mechanism. Circ Res 2002; 91: 712-718
20. Tousoulis D, Davies G, Stefanadis C, Toutouzas P, Ambrose JA: Inflammatory and thrombotic mechanisms in coronary atherosclerosis, Heart 2003; 89: 993-997
21. Gieche J, Mehlhase J, Licht A, Zacke T, Sitte N, Grune T: Protein oxidation and proteolysis in RAW264.7 macrophages : Effects of PMA activation. Biochim Biophys Acta 2001; 1538: 321-328
22. Antonicelli F, Brown D, Parmentier M, Drost EM, Hirani N, Rahman I, Donaldson K, MacNee W: Regulation of LPS-mediated inflammation in vivo and in vitro by the thiol antioxidant Nacystelyn. Am J Physiol Lung Cell Mol Physiol2004; 286: L1319-L1327
23. Svensson PA, Asea A, Englund MC, Bausero MA, Jernas M, Wiklund O, Ohlsson BG, Carlsson LM, Carlsson B: Major role of HSP7CTas a paracrine inducer of cytokine production in human oxidized LDL treated macrophages. Atherosclerosis 2006; 185: 32-38
24. Buczynski A, Wachowicz B, Kedziora-Kornatowska K, Tkaczewski W, Kedziora J: Changes in antioxidant enzymes activities, aggregability and malonyldialdehyde concentration in blood platelets from patients with coronary heart disease. Atherosclerosis 1993; 100: 223-228
25. Yegin A, Yegin H, Aliciguzel Y, Deger N, Semiz E: Erythrocyte selenium-glutathione peroxidase activity is lower in patients with coronary atherosclerosis. Jpn Heart J 1997; 38: 793-798
26. Lapenna D, de Gioia S, Ciofani G, Mezzetti A, Ucchino S, Calafiore AM, Napolitano AM, Di Ilio C, Cuccurullo F: Glutathione-related antioxidant defenses in human atherosclerotic plaques. Circulation 1998; 97: 1930-1934
27. Kesavulu MM, Rao BK, Giri R, Vijaya J, Subramanyam G, Apparao C: Lipid peroxidation and antioxidant enzyme status in Type 2 diabetics with coronary heart disease. Diabetes Res Clin Pract 2001; 53: 33-39
28. Hamanishi T, Furuta H, Kato H, Doi A, Tamai M, Shimomura H, Sakagashira S, Nishi M, Sasaki H, Sanke T, Nanjo K: Functional variants in the glutathione peroxi-dase-1 (GPx-l)gene are associated with increased intima-media thickness of carotid arteries and risk of macrovascu-lar diseases in Japanese type 2 diabetic patients. Diabetes 2004; 53: 2455-2460
29. Blankenberg S, Rupprecht HJ, Bickel C, Torzewski M, Hafner G, Tiret L, Smieja M, Cambien F, Meyer J, Lackner KJ; AtheroGene Investigators: Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med 2003; 349: 1605 -1613 30) Ohsawa M, Tsuru R, Hojo Y, Mizuno O, Fukazawa H, Mitsuhashi T, Katsuki T, Shimada K: Relationship between redox state of whole arterial blood glutathione and left ventricular function after acute myocardial infarction. J Cardiol2004; 44: 141-146 (in Jpn withEng abstr)